Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Posted inNeuroscience, New Drugs, Regulatory
Lyfnua: First Drug for Refractory or Unexplained Chronic Cough
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.
Posted inNew Drugs, Regulatory
Susvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration
Roche offered a convenient replacement for the traditional Lucentis.
Posted inInfections, New Drugs, Regulatory
Brexafemme: New Drug for Vaginal Yeast Infection
Scynexis offered ibrexafungerp, a new antifungal medication for vulvovaginal candidiasis treatment.
Posted inNeuroscience, New Drugs, Regulatory
Quviviq: New Sleeping Pill
Daridorexant will help treat insomnia.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Molnupiravir Approved in the U.S.
An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.
